esophageal disease: A non-neoplastic or neoplastic disorder that affects the esophagus. Representative examples of non-neoplastic disorders include esophagitis and esophageal ulcer. Representative examples of neoplastic disorders include carcinomas, lymphomas, and melanomas.
Disorders of oesophagus in diseases classified elsewhere
DOID EFO Endpoint Browser PheWeb
K11_DISOESINOTH
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
712 |
4. Check minimum number of eventsNone |
712 |
5. Include endpointsNone |
712 |
6. Filter based on genotype QC (FinnGen only) |
712 |
Control definitions (FinnGen only)
- Control exclude
- K11_OESSTODUO
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Disorders of oesophagus in diseases classified elsewhere
based on the number of shared cases.
Similar with more cases:
- Diseases of oesophagus, stomach and duodenum
- Gastrointestinal diseases
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4359 | 2111 | 2210 |
| Only index persons | 3741 | 1874 | 1867 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.06 | 0.06 |
| Only index persons | 0.07 | 0.07 | 0.07 |
| Median age at first event (years) | |||
| Whole population | 68.90 | 69.62 | 68.24 |
| Only index persons | 68.35 | 68.82 | 67.87 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 712 | 350 | 362 |
| Unadjusted period prevalence (%) | 0.14 | 0.12 | 0.16 |
| Median age at first event (years) | 66.42 | 64.22 | 68.54 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 643
- Matched controls
- 6430
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
55.7
323.0
554
645
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
4503599627370496.0
323.0
540
*
J02AC01
ATC
fluconazole; systemic
8.0
127.1
448
1438
K23.8
ICD-10 Finland
Disorders of oesophagus in other diseases classified elsewhere
+∞
126.3
117
*
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
47.2
118.1
144
39
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
22.9
72.2
106
55
A02BC02
ATC
pantoprazole; systemic
4.9
67.0
518
2933
A07AA02
ATC
nystatin; oral
10.3
65.9
138
166
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.2
63.3
422
2017
UJF32
NOMESCO Finland
Coloscopy
4.6
63.1
290
979
J45.9
ICD-10 Finland
Asthma, unspecified
5.2
60.6
226
608
H02AB06
ATC
prednisolone; systemic
4.0
60.1
424
2089
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.4
60.1
292
1028
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.8
54.4
175
390
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
10.3
52.5
108
123
A02BC05
ATC
esomeprazole; systemic
3.7
51.5
333
1452
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
4.3
50.5
227
717
K29.3
ICD-10 Finland
Chronic superficial gastritis
141.1
49.6
52
*
R13
ICD-10 Finland
Dysphagia
9.6
49.0
105
128
K29.7
ICD-10 Finland
Gastritis, unspecified
72.0
46.9
53
8
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.5
45.1
288
1203
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
7.3
43.3
111
179
B37.8
ICD-10 Finland
Candidiasis of other sites
229.9
42.4
43
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.1
42.2
193
604
H02AB04
ATC
methylprednisolone; systemic
4.4
40.8
172
496
R03BB04
ATC
tiotropium bromide; inhalant
5.0
40.4
143
345
C03CA01
ATC
furosemide; systemic
3.2
40.3
293
1319
A02BC01
ATC
omeprazole; systemic
3.4
40.2
254
1033
R03AC02
ATC
salbutamol; inhalant
3.0
38.4
393
2214
D64.9
ICD-10 Finland
Anaemia, unspecified
4.8
37.0
135
334
K22.1
ICD-10 Finland
Ulcer of oesophagus
+∞
36.8
35
*
UJD02
NOMESCO Finland
Gastroscopy
11.2
35.8
69
68
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.0
35.6
305
1500
N02AX02
ATC
tramadol; systemic, rectal
2.9
35.5
350
1887
K20
ICD-10 Finland
Oesophagitis
83.0
35.2
39
5
R03AK06
ATC
salmeterol and fluticasone; inhalant
4.0
35.1
163
507
R06.0
ICD-10 Finland
Dyspnoea
3.2
34.5
237
997
R03DC03
ATC
montelukast; oral
4.0
33.8
154
469
J01MA12
ATC
levofloxacin; systemic
3.5
33.6
191
696
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.2
32.9
139
394
J45.0
ICD-10 Finland
Predominantly allergic asthma
5.6
32.0
99
201
K22.2
ICD-10 Finland
Oesophageal obstruction
328.0
31.1
31
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.6
31.1
117
295
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
3.8
31.1
152
489
L04AX01
ATC
azathioprine; systemic
8.8
30.9
68
85
UGC12
NOMESCO Finland
Flexible bronchoscopy
5.2
30.9
103
228
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
7.7
30.8
74
107
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.4
30.3
175
639
N03AX16
ATC
pregabalin; oral
3.0
29.4
210
891
A06AD11
ATC
lactulose; oral
3.6
29.3
150
499
J01MA14
ATC
moxifloxacin; systemic
4.5
29.0
111
284
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
157.0
28.9
30
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
6.4
28.2
77
133
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
5.7
28.0
85
168
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
39.8
27.3
34
9
J45
ICD-10 Finland
Asthma
4.4
27.3
107
279
UJF30
NOMESCO Finland
Ileoscopy through colon
4.7
27.1
98
236
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.9
26.9
121
358
A02BA02
ATC
ranitidine; systemic
3.1
26.9
172
671
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
146.1
26.8
28
*
A02BC03
ATC
lansoprazole; oral
2.7
26.6
233
1110
R11
ICD-10 Finland
Nausea and vomiting
5.1
26.4
88
194
R03BA05
ATC
fluticasone; inhalant
3.2
26.0
163
625
H02AB07
ATC
prednisone; oral
3.5
25.9
139
475
K30
ICD-10 Finland
Functional dyspepsia
5.7
25.5
77
151
J01.0
ICD-10 Finland
Acute maxillary sinusitis
3.1
25.4
163
634
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
4.0
25.3
111
321
J45.1
ICD-10 Finland
Nonallergic asthma
4.9
25.3
88
203
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.4
24.8
96
247
R10.1
ICD-10 Finland
Pain localized to upper abdomen
3.4
24.6
132
448
127
Kela drug reimbursment
Transplant complication
20.0
24.2
36
19
L04AD01
ATC
ciclosporin; systemic
15.9
24.1
39
26
A01AB09
ATC
miconazole; local oral
4.1
23.8
99
272
K92.0
ICD-10 Finland
Haematemesis
13.6
23.7
41
32
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.2
23.4
76
162
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.0
23.3
158
633
K92.1
ICD-10 Finland
Melaena
5.7
22.6
67
128
R01AD08
ATC
fluticasone; nasal
2.6
22.2
201
957
TGC00
NOMESCO Finland
Bronchial lavation
9.1
22.2
47
55
R03BA01
ATC
beclometasone; inhalant
3.1
21.8
135
507
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
83.1
21.8
24
*
L04AA06
ATC
mycophenolic acid; systemic
13.9
21.7
37
28
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.5
21.5
108
348
R50.9
ICD-10 Finland
Fever, unspecified
3.1
21.1
133
504
K22.4
ICD-10 Finland
Dyskinesia of oesophagus
+∞
20.9
20
*
K25.3
ICD-10 Finland
Gastric ulcer, Acute without haemorrhage or perforation
+∞
20.9
20
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.9
20.6
90
257
AA1AD
NOMESCO Finland
CT of head and brain
2.5
20.5
207
1036
J01MA02
ATC
ciprofloxacin; systemic
2.2
20.5
294
1756
A06AC01
ATC
ispaghula (psylla seeds); oral
2.5
20.3
192
927
A03FA02
ATC
cisapride; oral, rectal
4.2
20.2
80
209
J01FF01
ATC
clindamycin; systemic
2.4
19.9
206
1046
XG410
NOMESCO Finland
Flow-volume spirometry
6.6
19.8
52
85
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
5.6
19.8
59
114
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
6.9
19.7
50
78
E0000UV
ATC
NA
2.2
19.7
276
1621
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.2
19.4
339
2189
H02AB09
ATC
hydrocortisone; systemic
9.8
19.4
39
42
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.2
19.2
108
377
N17.9
ICD-10 Finland
Acute renal failure, unspecified
5.7
19.1
56
106
A03FA01
ATC
metoclopramide; systemic, rectal
2.6
19.1
168
779
R96
ICPC
Asthma
3.9
19.1
82
231
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.5
19.0
95
303
TK800
NOMESCO Finland
Hemodialysis
9.4
18.9
39
44
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.7
18.8
66
153
R03AK07
ATC
formoterol and budesonide; inhalant
2.7
18.6
143
612
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.0
18.6
117
441
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.6
18.5
152
673
R03AC12
ATC
salmeterol; inhalant
5.3
18.5
58
119
N02BE01
ATC
paracetamol; systemic, rectal
2.7
18.4
562
4635
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.3
18.3
100
340
E87.6
ICD-10 Finland
Hypokalaemia
6.8
17.8
45
70
WW500
NOMESCO Finland
Blood transfusion
5.7
17.8
52
98
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
6.7
17.6
45
71
N03AX12
ATC
gabapentin; oral
2.8
17.5
125
510
P01AB01
ATC
metronidazole; oral, rectal
2.1
17.4
266
1597
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
6.7
17.2
44
70
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.7
17.2
131
554
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.2
17.1
243
1410
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
4.6
17.1
61
144
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
17.0
166
805
N06AX11
ATC
mirtazapine; oral
2.2
16.8
222
1244
UJF92
NOMESCO Finland
Capsular endoscopy
13.1
16.8
29
23
K25.7
ICD-10 Finland
Gastric ulcer, Chronic without haemorrhage or perforation
+∞
16.7
16
*
JN4BD
NOMESCO Finland
Extensive body CT
2.9
16.6
109
418
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.9
16.6
55
120
ZX120
NOMESCO Finland
Intravenous
3.3
16.4
86
284
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
3.1
16.4
97
349
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.3
16.3
88
297
J01FA06
ATC
roxithromycin; oral
2.1
16.2
275
1710
Z01.8
ICD-10 Finland
Other specified special examinations
2.4
16.2
160
781
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
48.8
16.1
19
*
N02AA05
ATC
oxycodone; systemic
2.6
16.0
131
577
J46
ICD-10 Finland
Status asthmaticus
6.6
15.9
41
66
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
6.6
15.9
41
66
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
3.7
15.9
72
212
J01DB01
ATC
cefalexin; oral
2.2
15.9
519
4191
A10AE04
ATC
insulin glargine; parenteral
3.2
15.7
88
304
JN4AD
NOMESCO Finland
Body CT examination
3.5
15.7
77
242
N06AX21
ATC
duloxetine; oral
3.2
15.7
87
299
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
19.8
15.6
23
12
K29.9
ICD-10 Finland
Gastroduodenitis, unspecified
87.2
15.6
17
*
K29.8
ICD-10 Finland
Duodenitis
163.8
15.5
16
*
R03DA04
ATC
theophylline; systemic, rectal
3.9
15.5
66
184
E000001
ATC
NA
2.4
15.4
151
731
R03BA02
ATC
budesonide; inhalant
2.5
15.4
134
607
R07.4
ICD-10 Finland
Chest pain, unspecified
2.2
15.3
194
1063
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.1
15.2
61
161
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.9
15.2
99
380
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
4.1
15.0
59
153
R03BA08
ATC
ciclesonide; inhalant
3.6
14.8
70
213
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
14.8
194
1072
JN3AD
NOMESCO Finland
Abdominal CT examination
3.4
14.8
74
236
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
4.1
14.7
59
156
A02BC04
ATC
rabeprazole; oral
3.7
14.6
65
188
R06AE07
ATC
cetirizine; oral
2.0
14.6
271
1725
R63.8
ICD-10 Finland
Other symptoms and signs concerning food and fluid intake
82.0
14.6
16
*
R63.4
ICD-10 Finland
Abnormal weight loss
5.2
14.6
45
91
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.9
14.6
95
364
J01CA04
ATC
amoxicillin; systemic
2.1
14.3
498
4005
SPAT1263
SPAT
Sampling
2.0
14.3
286
1870
N05CF01
ATC
zopiclone; oral
2.0
14.2
233
1412
R53
ICD-10 Finland
Malaise and fatigue
2.3
14.2
151
756
ZXD05
NOMESCO Finland
Urgent procedure
2.0
14.2
222
1321
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
3.9
14.1
59
162
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.3
13.9
72
236
R03BB01
ATC
ipratropium bromide; inhalant
4.6
13.8
48
111
C03DA01
ATC
spironolactone; oral
2.7
13.6
98
399
R60.0
ICD-10 Finland
Localized oedema
2.7
13.6
97
392
J01AA02
ATC
doxycycline; systemic
2.0
13.6
497
4021
K29.0
ICD-10 Finland
Acute haemorrhagic gastritis
142.9
13.5
14
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.5
13.5
111
488
N06AB04
ATC
citalopram; systemic
2.2
13.3
152
786
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.8
13.2
91
361
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
3.2
13.1
71
240
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.9
13.1
290
1948
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
17.2
13.0
20
12
J01FA15
ATC
telithromycin; oral
3.1
13.0
73
252
R01AD09
ATC
mometasone; nasal
1.9
12.9
264
1725
GD1AD
NOMESCO Finland
Thorax CT examination
4.3
12.9
48
119
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.5
12.8
112
508
R51.80
ICD-10 Finland
Headache
2.6
12.7
97
406
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
3.7
12.6
55
157
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
4.8
12.5
41
89
R05
ICD-10 Finland
Cough
2.2
12.5
137
694
K26.3
ICD-10 Finland
Duodenal ulcer, acute without haemorrhage or perforation
132.5
12.5
13
*
K25.0
ICD-10 Finland
Gastric ulcer, Acute with haemorrhage
132.5
12.5
13
*
WX002
NOMESCO Finland
Sedation and analgesia
2.2
12.5
146
760
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
5.5
12.4
36
68
TDM10
NOMESCO Finland
Puncture of maxillary antrum
5.1
12.4
39
81
R03AC03
ATC
terbutaline; inhalant
2.5
12.4
101
439
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
4.9
12.3
40
86
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.5
12.3
36
69
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.9
12.2
220
1362
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.7
12.1
88
358
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.0
12.0
175
1000
A46
ICD-10 Finland
Erysipelas
2.3
12.0
116
553
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.9
12.0
208
1273
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.4
11.9
58
181
L28
ICPC
Limited function/disability (L)
2.2
11.8
128
642
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
5.4
11.8
35
68
J01FA09
ATC
clarithromycin; systemic
2.0
11.7
195
1171
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.8
11.7
50
141
A41.9
ICD-10 Finland
Sepsis, unspecified
4.7
11.7
39
87
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
3.8
11.6
49
136
E87.5
ICD-10 Finland
Hyperkalaemia
7.4
11.6
27
38
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
3.1
11.6
66
231
L04AA01
ATC
[U] ciclosporin; systemic
9.5
11.6
23
25
NF1AA
NOMESCO Finland
Hip X-ray examination
2.9
11.5
74
279
SPAT1325
SPAT
Vaccination
1.8
11.5
248
1633
K22.5
ICD-10 Finland
Diverticulum of oesophagus, acquired
+∞
11.5
11
*
M81.9
ICD-10 Finland
Osteoporosis, unspecified
4.5
11.5
40
93
ZXE20
NOMESCO Finland
More than three and less than five hours
2.3
11.5
111
529
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.6
11.4
52
154
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
7.2
11.4
27
39
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.8
11.4
268
1810
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.6
11.4
39
89
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.9
11.4
73
275
N04BC05
ATC
pramipexole; oral
3.1
11.4
62
211
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
3.0
11.3
66
235
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.2
11.3
128
654
SPAT1249
SPAT
Treatment-related counselling outside office
1.8
11.2
259
1738
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
5.2
11.2
34
68
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.2
11.2
42
105
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.5
11.2
52
157
A07EA06
ATC
budesonide; oral, local oral
5.6
11.2
32
60
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
3.2
11.1
58
191
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.2
11.1
121
607
SPAT1255
SPAT
Intravenous administration of medicine
3.0
11.1
65
233
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
5.2
10.9
33
66
M48.0
ICD-10 Finland
Spinal stenosis
2.4
10.9
97
440
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
4.1
10.9
42
108
-
ICD-10 Finland
NA
5.4
10.9
32
62
Z49.1
ICD-10 Finland
Extracorporeal dialysis
8.5
10.9
23
28
N06AA09
ATC
amitriptyline; systemic
2.6
10.9
81
335
137
Kela drug reimbursment
Uraemia requiring dialysis
15.8
10.9
17
11
I50.9
ICD-10 Finland
Heart failure, unspecified
2.2
10.9
118
593
R02
ICPC
Shortness of breath/dyspnoea
2.5
10.9
90
396
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
7.4
10.8
25
35
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
6.0
10.8
29
50
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.0
10.8
170
994
A10AA02
ATC
NA
5.0
10.8
34
71
C08CA05
ATC
nifedipine; systemic
3.0
10.8
62
218
I10
ICD-10 Finland
Essential (primary) hypertension
1.8
10.8
401
3115
K29.4
ICD-10 Finland
Chronic atrophic gastritis
18.2
10.8
16
9
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
21.9
10.7
15
7
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
5.7
10.7
30
55
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.3
10.6
105
504
A01AB04
ATC
amphotericin B; local oral
3.9
10.5
43
117
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
3.1
10.5
59
204
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
7.0
10.5
25
37
K25.4
ICD-10 Finland
Gastric ulcer, Chronic or unspecified with haemorrhage
+∞
10.4
10
*
R03AK08
ATC
formoterol and beclometasone; inhalant
4.6
10.4
35
79
B01AB05
ATC
enoxaparin; parenteral
1.8
10.4
209
1333
H04.10
ICD-10 Finland
Dry eye syndrome
2.7
10.4
71
278
A11CC03
ATC
alfacalcidol; systemic
5.9
10.4
28
49
J20
ICD-10 Finland
Acute bronchitis
2.8
10.4
69
268
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
23.8
10.3
14
6
K59.0
ICD-10 Finland
Constipation
3.6
10.3
45
130
A10AA01
ATC
NA
6.4
10.2
26
42
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.3
10.2
51
163
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.9
10.2
62
226
R42
ICD-10 Finland
Dizziness and giddiness
2.0
10.1
150
856
N05AH04
ATC
quetiapine; oral
2.3
10.1
100
480
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
10.1
247
1675
C07AB07
ATC
bisoprolol; oral
1.7
10.1
325
2398
B03BA03
ATC
hydroxocobalamin; parenteral
3.4
10.1
49
154
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.1
10.0
118
612
K29.6
ICD-10 Finland
Other gastritis
40.7
10.0
12
*
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
5.4
9.9
29
56
M79.6
ICD-10 Finland
Pain in limb
1.8
9.9
215
1401
Z2446
NOMESCO Finland
Social worker
3.1
9.9
53
179
N03AE01
ATC
clonazepam; systemic
3.4
9.9
48
151
A02BA04
ATC
nizatidine; systemic
2.8
9.8
62
233
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
4.1
9.8
37
94
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.8
9.8
65
252
XW000
NOMESCO Finland
Bone marrow biopsy
3.9
9.8
39
104
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.7
9.8
66
259
B01AC04
ATC
clopidogrel; oral
2.1
9.7
126
681
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
5.0
9.7
30
62
T89
ICPC
Diabetes insulin dependent
4.7
9.7
32
71
J01DA01
ATC
[U] cefalexin; systemic
1.7
9.7
384
2995
K29.1
ICD-10 Finland
Other acute gastritis
55.8
9.7
11
*
K22.7
ICD-10 Finland
Barrett oesophagus
55.8
9.7
11
*
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.9
9.7
169
1022
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.5
9.6
77
332
A07EC02
ATC
mesalazine; oral, rectal
3.5
9.6
44
132
K51.5
ICD-10 Finland
Left sided colitis
5.8
9.6
26
46
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.6
9.6
70
286
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
15.3
9.5
15
10
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.0
9.5
54
188
C08CA01
ATC
amlodipine; oral
1.7
9.5
250
1725
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
5.3
9.5
28
55
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.5
9.5
43
128
K22.8
ICD-10 Finland
Other specified diseases of oesophagus
101.5
9.4
10
*
C01DA14
ATC
isosorbide mononitrate; oral
2.1
9.4
118
629
M01AB55
ATC
diclofenac, combinations; oral
2.8
9.4
59
221
K22.9
ICD-10 Finland
Disease of oesophagus, unspecified
+∞
9.4
9
*
Z94.2
ICD-10 Finland
Lung transplant status
+∞
9.4
9
*
K26.9
ICD-10 Finland
Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation
+∞
9.4
9
*
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.7
9.4
228
1537
WX892
NOMESCO Finland
Monitored bed care
2.8
9.3
62
240
J47
ICD-10 Finland
Bronchiectasis
6.6
9.3
23
36
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
4.2
9.3
34
84
J01FA10
ATC
azithromycin; systemic
1.7
9.3
317
2358
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.8
9.3
172
1060
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
2.1
9.3
115
610
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
4.4
9.2
32
75
R01AD01
ATC
beclometasone; nasal
2.2
9.2
100
500
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
3.2
9.1
47
155
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.9
9.1
155
926
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
3.5
9.1
41
122
V03AE01
ATC
polystyrene sulfonate; oral
9.2
9.1
18
20
SPAT1262
SPAT
Handing over of treatment supplies
2.0
9.0
135
769
Z94.4
ICD-10 Finland
Liver transplant status
37.2
9.0
11
*
J05AB11
ATC
valaciclovir; oral
2.3
9.0
88
418
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
6.7
9.0
22
34
M05BX04
ATC
denosumab; parenteral
3.3
9.0
45
145
A07EC01
ATC
sulfasalazine; oral, rectal
2.7
9.0
60
233
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.1
9.0
113
602
B07.9
ICD-10 Finland
Verruca simplex
4.6
9.0
30
68
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
8.1
8.9
19
24
N05CD07
ATC
temazepam; oral
2.2
8.9
98
493
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.1
8.8
48
164
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
9.7
8.8
17
18
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.7
8.8
272
1953
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
5.0
8.8
27
56
K90.0
ICD-10 Finland
Coeliac disease
5.0
8.8
27
56
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
3.6
8.7
38
110
JJC00
NOMESCO Finland
Allogenic transplantation of liver
50.7
8.7
10
*
R01BA52
ATC
pseudoephedrine, combinations; oral
1.8
8.7
186
1198
K50.0
ICD-10 Finland
Crohn disease of small intestine
11.8
8.6
15
13
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.9
8.6
50
179
A05AA02
ATC
ursodeoxycholic acid; oral
10.2
8.6
16
16
S18
ICPC
Laceration/cut
1.7
8.6
265
1902
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.5
8.6
68
293
P01BA02
ATC
hydroxychloroquine; oral
2.6
8.5
61
247
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.4
8.5
40
123
K59.1
ICD-10 Finland
Functional diarrhoea
3.4
8.4
40
124
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.9
8.4
52
191
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
4.0
8.4
32
83
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.0
8.4
48
170
GDG10
NOMESCO Finland
Bilateral transplantation of lung
+∞
8.3
8
*
K31.8
ICD-10 Finland
Other specified diseases of stomach and duodenum
+∞
8.3
8
*
K26.0
ICD-10 Finland
Duodenal ulcer, acute with haemorrhage
+∞
8.3
8
*
M05BA04
ATC
alendronic acid; oral
2.4
8.3
69
303
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
10.9
8.3
15
14
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
3.4
8.3
39
120
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.9
8.3
144
863
L04AA13
ATC
leflunomide; oral
5.1
8.3
25
51
B81
ICPC
Anaemia vit B12/folate deficiency
3.8
8.3
34
94
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.8
8.2
165
1036
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.9
8.2
49
179
K83.0
ICD-10 Finland
Cholangitis
7.0
8.1
19
28
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
8.1
128
743
B37.08
ICD-10 Finland
Other candidal stomatitis
11.9
8.1
14
12
H26.3
ICD-10 Finland
Drug-induced cataract
17.4
8.1
12
7
M34.1
ICD-10 Finland
CR(E)ST syndrome
33.8
8.1
10
*
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
3.7
8.1
34
96
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
5.4
8.1
23
44
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
6.4
8.1
20
32
A07AA09
ATC
vancomycin; oral
6.4
8.1
20
32
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.0
8.0
46
163
WX872
NOMESCO Finland
Intensive care
2.9
8.0
47
170
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.8
8.0
51
194
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
5.0
8.0
24
49
3AC01
NOMESCO Finland
NA
13.2
7.9
13
10
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
5.5
7.9
22
41
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
4.1
7.9
29
73
A02BA03
ATC
famotidine; systemic
3.9
7.9
31
83
N30
ICD-10 Finland
Cystitis
2.8
7.8
49
182
Z49.2
ICD-10 Finland
Other dialysis
11.0
7.8
14
13
A04AA01
ATC
ondansetron; systemic, rectal
2.9
7.8
47
173
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.2
7.8
39
127
UJC12
NOMESCO Finland
Flexible oesophagoscopy
15.2
7.7
12
8
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
5.7
7.7
21
38
UJF02
NOMESCO Finland
Peroral enteroscopy
45.5
7.7
9
*
I50.0
ICD-10 Finland
Congestive heart failure
2.5
7.7
60
256
M05BA07
ATC
risedronic acid; oral
3.6
7.7
33
95
W19
ICD-10 Finland
Unspecified fall
2.3
7.7
72
335
UKC02
NOMESCO Finland
Cystoscopy
1.9
7.7
116
663
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
4.0
7.6
29
75
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.9
7.6
30
80
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
6.8
7.6
18
27
4931A
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]
8.2
7.6
16
20
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.9
7.6
44
157
SPAT1301
SPAT
No procedures
1.7
7.6
199
1352
K86.1
ICD-10 Finland
Other chronic pancreatitis
12.0
7.6
13
11
I45.9
ICD-10 Finland
Conduction disorder, unspecified
12.0
7.6
13
11
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
6.3
7.6
19
31
4931B
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]
25.3
7.6
10
*
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
25.3
7.6
10
*
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.9
7.6
45
164
Z94.0
ICD-10 Finland
Kidney transplant status
9.0
7.6
15
17
M54.5
ICD-10 Finland
Low back pain
1.7
7.6
185
1231
Z3226
NOMESCO Finland
Physiotherapist
1.9
7.5
118
679
J45.8
ICD-10 Finland
Mixed asthma
4.2
7.5
27
67
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.6
7.4
54
220
A12AA04
ATC
calcium carbonate; oral
5.7
7.4
20
36
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
7.8
7.4
16
21
A04.8
ICD-10 Finland
Other specified bacterial intestinal infections
7.8
7.4
16
21
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
4.4
7.4
25
58
103
Kela drug reimbursment
Diabetes, insulin-treated
1.7
7.4
178
1179
R4180
NOMESCO Finland
Podiatric therapy
8.5
7.3
15
18
315
Kela drug reimbursment
Clopidogrel
8.5
7.3
15
18
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
8.5
7.3
15
18
TKC20
NOMESCO Finland
Catheterisation of bladder
2.5
7.3
58
250
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
7.3
115
664
H04AA01
ATC
glucagon; nasal, parenteral
7.0
7.3
17
25
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.7
7.3
180
1199
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.4
7.3
18
29
SBA00
NOMESCO Finland
Microbiological examinations
4.7
7.3
23
50
S97
ICPC
Chronic ulcer skin
2.6
7.3
50
199
A10AE05
ATC
insulin detemir; parenteral
2.9
7.2
42
151
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.3
7.2
69
325
SPAT1312
SPAT
General health counselling
1.7
7.2
190
1291
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.2
7.2
35
112
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
4.6
7.1
23
51
D07AC01
ATC
betamethasone; topical
1.6
7.1
205
1428
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.0
7.1
88
466
N06AX16
ATC
venlafaxine; oral
2.2
7.1
73
357
H3603, E103
ICD-10 Finland
NA
10.2
7.1
13
13
WX882
NOMESCO Finland
High dependency care
3.9
7.0
27
71
M01AE03
ATC
ketoprofen; systemic, rectal
1.6
7.0
236
1709
D21
ICPC
Swallowing problem
7.1
7.0
16
23
N30.0
ICD-10 Finland
Acute cystitis
2.0
7.0
89
475
G04CA02
ATC
tamsulosin; oral
1.7
7.0
163
1067
R12
ICD-10 Finland
Heartburn
2.9
7.0
41
149
R06AX22
ATC
ebastine; oral
2.0
6.9
96
528
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
7.6
6.9
15
20
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
3.1
6.9
36
121
M02AA07
ATC
piroxicam; topical
1.6
6.9
226
1623
SPAT1254
SPAT
Administration of medicine
1.9
6.9
105
600
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
6.9
108
622
R06AX13
ATC
loratadine; oral
2.1
6.9
82
425
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.7
6.9
155
1007
A12BA01
ATC
potassium chloride; oral
2.8
6.8
41
151
R95
ICPC
Chron obstructive pulmonary disease
3.9
6.8
26
68
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
6.8
146
933
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
4.6
6.8
22
49
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.0
6.8
37
128
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
11.1
6.8
12
11
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
11.1
6.8
12
11
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
6.2
6.8
17
28
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
5.8
6.8
18
32
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.4
6.8
56
245
N19
ICD-10 Finland
Unspecified kidney failure
3.2
6.8
33
106
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.6
6.7
228
1649
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.9
6.7
26
69
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
7.3
6.7
15
21
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
5.0
6.7
20
41
SPAT1104
SPAT
Monitoring of emergency patient
2.5
6.7
51
216
M81.4
ICD-10 Finland
Drug-induced osteoporosis
22.8
6.7
9
*
C07AB02
ATC
metoprolol; systemic
1.7
6.7
146
938
N18.8
ICD-10 Finland
Other chronic renal failure
3.7
6.7
27
75
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.8
6.6
26
70
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.7
6.6
157
1030
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
4.0
6.6
25
65
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
7.9
6.6
14
18
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.7
6.6
154
1006
K55.2
ICD-10 Finland
Angiodysplasia of colon
12.4
6.6
11
9
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
12.4
6.6
11
9
I20.09
ICD-10 Finland
Unstable angina
2.6
6.5
46
186
R04.2
ICD-10 Finland
Haemoptysis
3.4
6.5
29
87
D64.8
ICD-10 Finland
Other specified anaemias
5.4
6.5
18
34
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.1
6.5
75
383
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
3.5
6.5
28
82
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
3.5
6.5
28
82
J96.1
ICD-10 Finland
Chronic respiratory failure
4.3
6.5
22
52
C10AC01
ATC
colestyramine; oral
4.3
6.5
22
52
K81.0
ICD-10 Finland
Acute cholecystitis
4.8
6.5
20
43
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
4.8
6.5
20
43
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
3.7
6.4
26
72
M01AC06
ATC
meloxicam; systemic, rectal
1.6
6.4
215
1547
JCF12
NOMESCO Finland
Endoscopic insertion of prosthetic tube into oesphagus
70.5
6.4
7
*
K22.6
ICD-10 Finland
Gastro-oesophageal laceration-haemorrhage syndrome
70.5
6.4
7
*
R01AD05
ATC
budesonide; nasal
2.4
6.4
51
219
M35.1
ICD-10 Finland
Other overlap syndromes
14.5
6.4
10
7
GD2SN
NOMESCO Finland
Lung ventilation SPECT
14.5
6.4
10
7
GD1UN
NOMESCO Finland
Lung circulation SPECT
14.5
6.4
10
7
E11.1
ICD-10 Finland
Type 2 diabetes mellitus, with ketoacidosis
14.5
6.4
10
7
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.9
6.4
101
584
R03DC01
ATC
zafirlukast; oral
4.5
6.4
21
48
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
4.5
6.4
21
48
B01AB04
ATC
dalteparin; parenteral
2.8
6.4
39
146
SPAT1240
SPAT
Therapeutic discussion
2.4
6.4
52
229
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
4.3
6.4
22
53
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
3.7
6.4
26
73
N05BA06
ATC
lorazepam; systemic, sublingual
2.7
6.3
42
165
A09AA02
ATC
multienzymes (lipase, protease etc.)
4.7
6.3
20
44
B05DA
ATC
Isotonic solutions
11.2
6.3
11
10
ZX108
NOMESCO Finland
Inhalation
9.4
6.3
12
13
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
9.4
6.3
12
13
D07AA02
ATC
hydrocortisone; topical
2.0
6.3
78
413
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.2
6.3
31
101
V03AE02
ATC
sevelamer; oral
18.2
6.3
9
5
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
4.9
6.3
19
40
R33
ICD-10 Finland
Retention of urine
2.2
6.3
61
292
5301A
ICD-9 Finland
Diseases of oesophagus, Oesophagitis[OESOPHAGITIS REFLUENS]
+∞
6.3
6
*
K28.9
ICD-10 Finland
Gastrojejunal ulcer, unspecified as acute or chronic, without haemorrhage or perforation
+∞
6.3
6
*
Q40.9
ICD-10 Finland
Congenital malformation of upper alimentary tract, unspecified
+∞
6.3
6
*
A07DA03
ATC
loperamide; oral
3.1
6.3
32
107
K86.08
ICD-10 Finland
Alcohol-induced chronic pancreatitis
26.9
6.2
8
*
R03AK11
ATC
formoterol and fluticasone; inhalant
4.0
6.2
23
59
A01AB10
ATC
natamycin; local oral
4.0
6.2
23
59
N05BA01
ATC
diazepam; systemic, rectal
2.0
6.2
85
465
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
3.5
6.2
27
80
R03AC13
ATC
formoterol; inhalant
2.7
6.2
41
161
A02BD03
ATC
lansoprazole, amoxicillin and metronidazole; systemic
2.4
6.2
48
206
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
6.4
6.2
15
24
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
6.4
6.2
15
24
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
5.4
6.2
17
32
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.5
6.2
44
180
NHQ40
NOMESCO Finland
Amputation of toe
4.3
6.2
21
50
A06AC51
ATC
ispaghula, combinations; systemic
3.0
6.2
35
123
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
7.8
6.1
13
17
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.7
6.1
19
41
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.9
6.1
95
544
SPAT1229
SPAT
Assessment of need for aid
2.2
6.1
62
302
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.6
6.1
41
163
P76
ICPC
Depressive disorder
2.9
6.1
35
125
B03XA02
ATC
darbepoetin alfa; parenteral
4.5
6.1
20
46
R05
ICPC
Cough
1.7
6.1
130
826
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
3.5
6.1
26
76
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
8.7
6.1
12
14
N05BA04
ATC
oxazepam; oral
1.7
6.1
146
959
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
6.8
6.1
14
21
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
10.1
6.0
11
11
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.9
6.0
35
126
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
5.3
6.0
17
33
J30.0
ICD-10 Finland
Vasomotor rhinitis
4.0
6.0
22
56
J33.0
ICD-10 Finland
Polyp of nasal cavity
3.9
6.0
23
61
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
3.0
6.0
32
110
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
3.4
6.0
27
82
M02AA10
ATC
ketoprofen; topical
1.8
6.0
101
594
Z98.8
ICD-10 Finland
Other specified postsurgical states
6.1
6.0
15
25
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
6.1
6.0
15
25
81
HP
Angiography of the heart and coronary arteries
2.4
6.0
51
227
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768797) Stomach Pathology biopsy report
298
502
9.49
186.38
1.6
1.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
270
981
3.82
61.97
2.7
1.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
214
667
4.16
61.13
2.4
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
158
398
4.82
59.50
2.8
1.6
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72
82
9.66
58.85
13.5
5.2
iu/ml
344.9
160.6
1.56
23
11
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
332
1436
3.46
57.28
3.6
2.1
mg/l
3.5
3.1
1.55
299
1191
(3013115) Eosinophils [#/volume] in Blood
496
2795
3.55
54.36
10.9
5.6
e9/l
0.2
0.2
1.55
454
2428
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
357
1657
3.32
54.10
5.0
2.3
u/l
55.6
57.1
0.22
339
1519
(3019198) Lymphocytes [#/volume] in Blood
491
2757
3.52
53.97
10.4
5.4
e9/l
1.6
1.9
4.71
446
2389
(3020779) Urea [Moles/volume] in Serum or Plasma
168
478
4.29
53.74
12.9
6.1
mmol/l
11.6
10.5
0.85
161
444
(3006315) Basophils [#/volume] in Blood
484
2705
3.46
53.38
10.3
5.4
e9/l
0.0
0.0
0.43
443
2318
(3001604) Monocytes [#/volume] in Blood
482
2689
3.45
53.27
10.3
5.4
e9/l
0.6
0.6
1.88
442
2296
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
116
246
5.44
53.20
2.6
1.8
ug/l
1.3
2.2
0.33
105
214
(3023368) Bacteria identified in Blood by Culture
358
1681
3.27
52.91
8.7
4.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
238
881
3.56
51.78
3.7
2.2
umol/l
11.0
12.4
2.44
227
812
(3004789) Transferrin [Mass/volume] in Serum or Plasma
224
808
3.59
50.59
3.7
2.2
g/l
2.2
2.3
1.05
214
748
(3027945) Reticulocytes/100 erythrocytes in Blood
199
665
3.77
50.46
2.7
2.5
%
2.3
1.8
2.90
179
592
(3007853) Bacteria identified in Skin by Aerobe culture
196
660
3.72
49.00
2.4
1.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
212
754
3.58
48.73
3.8
2.3
%
20.4
22.0
0.80
180
641
(3005719) IgG [Mass/volume] in Serum or Plasma
142
396
4.23
46.22
3.5
2.6
g/l
10.1
10.5
0.35
130
357
(3001122) Ferritin [Mass/volume] in Serum or Plasma
418
2276
3.03
45.54
4.5
2.6
ug/l
160.7
145.7
0.50
388
2050
(3028026) IgM [Mass/volume] in Serum or Plasma
125
320
4.53
45.47
2.5
1.7
g/l
1.3
1.5
0.53
112
290
(3003458) Phosphate [Moles/volume] in Serum or Plasma
200
718
3.48
44.91
10.7
5.0
mmol/l
1.1
1.0
2.43
193
655
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
489
2929
3.14
44.36
12.2
6.0
umol/l
12.3
11.5
0.41
474
2771
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
79
138
6.31
44.27
2.2
1.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
140
399
4.12
44.12
7.9
4.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
513
3177
3.20
43.45
16.8
8.9
e9/l
4.7
4.2
4.36
478
2776
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
190
673
3.49
43.44
10.0
7.5
kpa
4.9
5.1
1.64
181
647
(3027801) Oxygen [Partial pressure] in Arterial blood
190
673
3.49
43.44
9.9
7.5
kpa
11.5
12.0
0.77
177
648
(3003396) Base excess in Arterial blood by calculation
189
672
3.47
42.90
10.0
7.6
mmol/l
1.6
1.4
0.18
147
524
(3024561) Albumin [Mass/volume] in Serum or Plasma
443
2543
2.96
42.85
9.7
4.3
g/l
32.7
35.2
14.08
424
2351
(3012095) Magnesium [Moles/volume] in Serum or Plasma
227
905
3.21
42.68
7.0
3.1
mmol/l
0.8
0.8
0.71
221
838
(3042936) Bacteria identified in Isolate by Culture
219
856
3.25
42.56
2.8
1.9
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
186
660
3.46
42.30
4.8
4.2
u/l
253.5
257.0
0.09
176
621
(3019309) Folate [Moles/volume] in Red Blood Cells
263
1149
3.04
42.08
2.0
1.7
nmol/l
1406.3
1197.7
2.34
200
824
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
190
695
3.36
41.03
2.7
1.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
350
1803
2.85
41.03
10.3
5.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
188
684
3.38
40.95
2.6
1.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
451
2658
2.90
40.72
12.6
5.7
mmol/l
1.2
1.2
8.08
407
2380
(3002032) Base excess in Venous blood by calculation
164
549
3.58
40.71
7.1
3.4
mmol/l
2.3
2.2
0.15
134
426
(3036481) Cortisol [Moles/volume] in Serum or Plasma
148
464
3.76
40.53
2.9
2.0
nmol/l
352.9
382.1
0.66
141
426
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
73
132
6.05
39.41
2.3
1.6
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
431
2519
2.80
38.87
10.8
5.5
%
2.5
2.8
2.97
408
2342
(3032080) INR in Blood by Coagulation assay
425
2468
2.79
38.78
14.3
10.0
inr
1.3
1.3
0.03
115
717
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
476
2935
2.88
38.55
13.4
6.3
mmol/l
1.2
1.2
8.02
401
2445
(3016502) Oxygen saturation in Arterial blood
171
608
3.39
38.43
10.6
7.8
%
94.9
95.7
0.85
161
589
(3019069) Monocytes/100 leukocytes in Blood
431
2532
2.78
38.25
11.6
5.8
%
8.9
8.8
0.06
410
2366
(3023520) Reticulocytes [#/volume] in Blood
153
509
3.55
38.17
2.8
2.6
e9/l
78.7
68.3
1.61
116
393
(3002030) Lymphocytes/100 leukocytes in Blood
436
2584
2.77
37.90
11.4
5.7
%
23.4
27.1
8.66
408
2400
(3018010) Neutrophils/100 leukocytes in Blood
430
2535
2.76
37.70
10.7
5.5
%
61.3
57.9
6.47
403
2372
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
87
195
4.94
37.01
3.6
3.0
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
418
2453
2.71
36.59
10.8
5.6
%
0.6
0.7
1.48
397
2286
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
77
158
5.34
36.25
1.6
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
59
95
6.68
35.66
2.2
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
48
62
8.23
35.27
2.3
1.5
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
65
117
6.01
35.19
4.2
2.0
umol/l
40.0
32.6
0.89
60
95
(3007164) IgA [Mass/volume] in Serum or Plasma
216
922
2.93
35.11
1.9
1.4
g/l
2.8
2.6
0.50
154
557
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
391
2251
2.63
35.11
6.6
3.7
ng/l
41.1
62.5
0.72
331
1666
(46235355) HIV 1 and 2 tests - Meaningful Use set
175
664
3.17
35.04
1.8
1.7
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
46
57
8.56
34.95
1.7
1.9
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
103
276
4.19
34.93
2.0
2.0
g/l
1.6
1.6
0.08
89
238
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
59
99
6.41
34.25
2.2
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
140
472
3.45
33.94
11.0
8.7
—
—
—
0
0
(3020891) Body temperature
93
236
4.38
33.85
8.5
4.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
334
1808
2.60
33.70
4.2
2.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
46
60
8.13
33.51
1.7
1.9
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
51
75
7.25
33.50
2.1
1.5
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
48
66
7.73
33.44
5.5
3.4
u/ml
694.0
3757.4
—
5
7
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
87
212
4.54
33.33
2.6
2.3
ug/l
286.6
321.8
0.18
82
201
(3013826) Glucose [Moles/volume] in Serum or Plasma
511
3415
2.76
32.84
10.6
4.6
mmol/l
7.0
6.7
1.44
498
3201
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
337
1855
2.55
32.53
4.2
2.9
ng/l
2040.9
1441.3
1.24
295
1598
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
43
54
8.41
32.29
1.4
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
43
54
8.41
32.29
1.4
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
43
54
8.41
32.29
1.4
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
145
519
3.25
31.78
3.2
2.4
ug/l
4.9
7.2
1.48
131
451
(3023419) Bacteria identified in Sputum by Culture
48
70
7.28
31.75
3.6
3.0
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
146
528
3.22
31.43
3.3
2.0
g/l
0.2
0.2
2.51
134
491
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
51
83
6.54
30.46
1.9
1.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
141
510
3.20
30.27
2.8
2.1
ug/g
184.0
159.7
0.34
117
394
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
321
1772
2.48
30.22
3.4
2.1
u/l
142.7
217.6
2.15
307
1665
(3002173) Hemoglobin [Mass/volume] in Arterial blood
149
566
3.06
29.35
11.5
8.3
g/l
112.3
121.2
5.59
143
545
(44790047)
45
68
7.00
28.79
2.2
1.4
—
—
—
0
0
(44806118)
45
68
7.00
28.79
2.2
1.4
—
—
—
0
0
(44790048)
45
68
7.00
28.79
2.2
1.4
—
—
—
0
0
(44790049)
45
68
7.00
28.79
2.2
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
264
1364
2.49
28.33
3.7
2.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
63
136
4.98
27.86
1.4
1.3
ug/g
253.6
283.2
0.47
38
77
(3024980) IgG subclass 4 [Mass/volume] in Serum
42
64
6.91
26.65
1.7
1.2
g/l
0.7
0.8
0.11
32
51
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
416
2683
2.32
26.24
6.3
3.9
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
113
392
3.24
25.79
13.7
6.7
mmol/l
24.3
24.5
0.21
106
367
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
365
2249
2.28
25.41
2.9
2.2
nmol/l
78.9
78.0
0.21
325
1960
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
43
71
6.38
25.28
2.0
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
231
1177
2.42
25.03
2.3
1.6
mg/l
1.2
1.2
0.13
175
919
(40760892) CBC W Ordered Manual Differential panel - Blood
229
1164
2.43
24.93
9.2
4.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
257
1378
2.35
24.75
12.4
6.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
313
1827
2.27
24.62
4.3
3.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
579
4388
2.71
24.42
17.1
7.1
u/l
84.9
78.9
1.30
567
4095
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
35
48
7.62
24.36
2.5
1.5
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
105
364
3.21
23.92
4.9
3.7
kpa
5.2
5.2
0.01
100
334
(3009343) pH of Capillary blood
103
357
3.20
23.45
5.0
3.8
ph
7.4
7.4
1.64
13
47
(3037522) Nuclear Ab [Titer] in Serum
154
671
2.65
23.04
1.5
1.3
titre
613.3
480.9
0.50
42
139
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
99
339
3.23
22.98
4.8
3.8
mmol/l
1.8
2.2
0.62
86
250
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
379
2437
2.19
22.97
2.6
2.0
pmol/l
92.8
94.3
0.28
227
1215
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
61
151
4.32
22.75
1.8
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
301
1777
2.20
22.53
8.3
3.8
ph
7.4
7.4
0.25
57
353
(3013707) Erythrocyte sedimentation rate by Westergren method
554
4181
2.46
22.34
7.9
3.9
mm/h
18.4
13.3
7.05
522
3808
(3011412) CD3 cells [#/volume] in Blood
31
41
7.86
22.23
1.6
2.1
e9/l
1.3
1.2
0.12
16
24
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
44
85
5.45
22.00
2.3
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
43
83
5.45
21.52
1.3
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
43
83
5.45
21.52
1.5
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
343
2160
2.13
21.48
6.2
3.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
325
2006
2.14
21.43
4.6
3.4
mmol/l
2.3
2.4
6.85
279
1740
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
40
74
5.67
20.94
1.6
1.4
u/ml
108.1
102.6
—
8
11
(3037692) Legionella sp identified in Specimen by Organism specific culture
22
20
11.32
20.75
1.7
1.5
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
85
282
3.29
20.72
6.0
3.4
%
51.0
45.2
1.28
85
276
(40761535) Cells panel - Urine sediment
125
518
2.71
20.50
7.0
3.4
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
27
34
8.21
20.14
1.4
1.1
g/l
3.5
2.5
1.15
19
26
(3024139) IgG subclass 3 [Mass/volume] in Serum
27
34
8.21
20.14
1.4
1.1
g/l
0.6
0.4
1.54
20
26
(3027135) IgG subclass 1 [Mass/volume] in Serum
27
34
8.21
20.14
1.4
1.1
g/l
7.0
8.4
0.51
20
26
(3018677) aPTT in Platelet poor plasma by Coagulation assay
179
887
2.36
20.07
2.9
1.9
s
30.3
29.8
0.37
174
854
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
285
1715
2.10
19.67
5.8
2.9
u/l
35.3
32.8
0.47
277
1627
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
64
183
3.74
19.57
2.3
1.3
g/l
1.1
1.2
0.92
59
173
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
24
27
9.16
19.52
1.7
2.3
e6/l
543.3
565.6
0.06
18
22
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
41
83
5.18
19.46
1.3
1.1
u/ml
342.3
256.7
0.93
26
50
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
83
283
3.19
19.31
9.6
10.7
mmol/l
24.6
24.8
0.16
74
267
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
130
567
2.58
19.16
1.9
1.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
120
505
2.66
19.01
3.3
2.8
g/l
62.9
66.4
4.55
103
455
(3048929) Epstein Barr virus Ab [Presence] in Serum
49
118
4.39
18.91
1.3
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
250
1457
2.10
18.57
1.9
1.5
nmol/l
22.1
20.7
0.15
212
1212
(4062490)
26
35
7.67
18.34
1.4
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
131
585
2.52
18.33
5.8
2.5
umol/l
9.1
8.4
0.17
115
516
(3004588) Protein electrophoresis panel - Serum or Plasma
106
427
2.74
18.27
3.3
2.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
116
490
2.63
18.20
1.9
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
114
479
2.64
18.07
6.3
3.9
%
1.0
0.9
0.39
60
142
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
24
30
8.24
17.98
1.3
2.1
%
18.3
10.8
1.20
14
13
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
190
1007
2.21
17.92
1.4
1.2
u/ml
2.3
1.4
0.28
46
269
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
65
200
3.48
17.80
3.6
2.3
u/ml
0.3
0.4
0.86
42
110
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
60
176
3.63
17.66
2.3
1.3
g/l
0.2
0.2
0.05
55
168
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
77
266
3.12
17.50
8.1
4.1
mmol/l
24.3
24.3
0.00
65
241
(3025941) Bacteria identified in Stool by Culture
78
274
3.07
17.22
1.6
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
216
1223
2.10
17.08
8.5
4.1
kg/l
1.0
1.0
0.95
38
159
(3011397) Hemoglobin [Presence] in Urine by Test strip
229
1327
2.07
17.00
7.5
3.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
91
353
2.81
16.80
2.2
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
22
27
8.38
16.71
1.5
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
22
27
8.38
16.71
1.5
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
22
27
8.38
16.71
1.5
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
22
27
8.38
16.71
1.5
1.9
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
106
448
2.61
16.55
5.1
3.6
ng/l
116.0
85.6
1.92
86
381
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
220
1271
2.06
16.37
1.8
1.7
pmol/l
36612508.5
14412204.5
0.26
183
1020
(3005322) IgE [Units/volume] in Serum or Plasma
76
271
3.02
16.34
1.6
1.2
u/ml
193.9
284.0
0.37
67
244
(3026493) Urate [Moles/volume] in Serum or Plasma
245
1476
2.01
16.19
4.5
2.8
umol/l
2140.4
8882.9
2.29
222
1264
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
23
31
7.63
16.19
1.4
2.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
508
3916
2.04
16.17
7.4
4.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
125
577
2.41
16.16
1.5
1.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
238
1421
2.01
16.12
9.1
3.7
%
88.5
88.5
0.01
225
1386
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
153
773
2.25
16.04
19.3
7.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
396
2819
1.91
15.79
7.5
3.7
estimate
0.0
0.0
0.00
68
525
(3021601) Nitrite [Presence] in Urine by Test strip
392
2787
1.90
15.63
9.2
5.0
estimate
0.0
0.0
0.00
72
536
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
30
56
5.55
15.54
6.1
3.8
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
391
2782
1.90
15.51
7.5
3.7
estimate
0.0
0.0
0.00
69
537
(3003181) Sodium [Moles/volume] in Urine
40
96
4.36
15.49
1.5
1.3
mmol/l
48.0
61.4
1.66
30
78
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
106
465
2.50
15.27
3.9
2.6
ml/min/173m2
54.3
64.2
1.64
50
186
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
44
115
4.01
15.24
1.6
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
44
115
4.01
15.24
1.6
1.3
—
—
—
0
0
(3026782) Osmolality of Urine
206
1188
2.03
15.24
4.6
2.7
mosm/kgh2o
506.5
560.8
3.72
187
1025
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
15
12
12.75
15.18
1.2
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
71
256
2.97
14.95
1.2
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
26
44
6.10
14.88
1.7
1.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
59
192
3.26
14.77
1.3
1.3
u/ml
1.0
1.9
—
7
15
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
66
230
3.06
14.74
2.7
1.8
—
—
—
0
0
(1616796) Gas panel - Central venous blood
44
118
3.91
14.72
5.2
3.6
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
51
152
3.54
14.65
3.7
2.7
mmol/l
24.9
25.3
0.31
45
127
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
23
35
6.76
14.55
2.3
1.9
e6/l
944.7
673.3
—
9
12
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
17
18
9.65
14.38
1.5
2.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
17
18
9.65
14.38
1.5
2.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
43
116
3.88
14.26
1.9
1.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
106
482
2.41
14.08
3.8
2.2
u/l
33.4
31.5
0.23
90
403
(3004809) Band form neutrophils/100 leukocytes in Blood
37
91
4.23
13.89
4.8
3.4
%
1.7
0.8
0.95
25
75
(4010399)
94
407
2.51
13.88
1.7
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
17
19
9.14
13.82
1.5
2.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
101
457
2.41
13.55
6.3
4.0
%
0.1
0.1
0.02
52
129
(3002179) Metamyelocytes/100 leukocytes in Blood
97
435
2.42
13.26
6.4
3.8
%
0.6
0.5
0.42
34
106
(3022313) Gas panel - Capillary blood
68
257
2.82
13.13
5.3
4.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
23
39
6.06
13.13
1.2
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
313
2156
1.81
13.03
8.1
3.9
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
14
13
10.97
12.89
1.6
1.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
46
140
3.44
12.80
1.6
1.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
147
797
2.06
12.62
33.0
27.7
inr
1.2
1.3
0.21
21
103
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
61
222
2.91
12.62
2.3
1.6
—
—
—
0
0
(3013512) EKG study
267
1766
1.82
12.62
5.6
3.9
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
23
41
5.76
12.49
2.4
2.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
241
1553
1.83
12.35
8.7
4.0
estimate
0.0
0.0
0.50
64
512
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
39
110
3.69
12.16
1.7
1.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
31
74
4.33
12.10
1.4
1.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
16
6
27.22
12.08
3.7
7.3
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
12
10
12.19
11.76
1.8
1.8
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
28
63
4.59
11.75
2.1
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
28
63
4.59
11.75
2.1
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
28
63
4.59
11.75
2.1
1.5
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
14
15
9.50
11.69
4.8
1.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
242
1583
1.80
11.68
5.7
3.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
104
508
2.23
11.62
2.2
1.7
%
1.7
1.5
2.34
86
425
(3024522) Salmonella sp identified in Specimen by Organism specific culture
28
64
4.51
11.53
2.1
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
28
64
4.51
11.53
2.1
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
28
64
4.51
11.53
2.1
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
35
95
3.82
11.52
1.3
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
184
1110
1.89
11.50
5.6
3.7
ng/l
430.5
275.1
0.58
152
903
(3000850) Epithelial cells [#/volume] in Urine
203
1266
1.84
11.42
4.4
2.5
e6/l
4.4
5.2
0.48
194
1130
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
41
125
3.42
11.39
2.4
1.3
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
20
34
6.02
11.38
3.2
2.8
%
42.7
38.3
—
6
9
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
44
141
3.26
11.30
1.7
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
444
3472
1.74
11.22
5.9
2.8
u/l
72.2
50.4
2.54
416
3197
(3007566) Smooth muscle Ab [Titer] in Serum
39
118
3.44
10.96
1.7
1.1
titre
296.0
70.0
—
5
7
(3006184) Hemoglobin [Mass/volume] in Capillary blood
39
119
3.41
10.82
2.9
2.1
g/l
123.2
128.3
0.58
28
92
(3021901) Oxygen saturation in Capillary blood
37
110
3.49
10.68
3.9
2.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
48
168
2.99
10.64
1.7
1.6
iu/ml
0.1
0.1
0.10
13
25
(3021879) Hepatitis B virus core Ab [Presence] in Serum
73
318
2.44
10.59
1.7
1.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
100
500
2.16
10.51
3.1
2.9
ng/l
290.9
216.2
0.54
91
466
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
45
153
3.07
10.49
3.4
2.2
%
84.9
91.3
0.87
40
143
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
169
1023
1.85
10.33
4.8
2.8
e6/l
0.8
1.1
1.05
121
593
(3030467) Casts [#/volume] in Urine by Automated count
247
1673
1.73
10.31
5.9
3.1
e6/l
0.5
0.5
0.10
218
1278
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
16
24
6.80
10.22
1.5
2.5
u/ml
757.3
977.4
0.47
16
24
(3028433) Virus identified in Specimen by Culture
15
21
7.28
10.16
1.1
1.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
188
1187
1.79
9.97
3.9
3.1
mmol/l
2.5
2.5
0.08
166
1059
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
386
2971
1.65
9.75
3.3
2.6
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
28
74
3.90
9.58
3.0
2.0
u/ml
616.9
5.9
0.74
28
68
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
62
263
2.49
9.52
2.7
2.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
29
79
3.78
9.52
3.0
3.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
306
2230
1.65
9.52
2.6
2.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
80
381
2.24
9.46
2.3
1.7
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
24
57
4.32
9.44
4.9
3.5
%
72.6
56.8
2.57
12
41
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
19
37
5.25
9.40
3.7
3.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
43
152
2.95
9.38
1.6
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
43
153
2.93
9.28
1.6
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
22
50
4.51
9.14
2.6
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
55
225
2.57
9.11
1.8
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
45
166
2.83
9.10
3.0
1.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
28
77
3.74
9.07
1.6
1.2
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
52
208
2.62
9.01
4.2
3.9
mg/l
72.8
57.8
0.24
41
169
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
52
208
2.62
9.01
4.3
4.0
mg/l
78.1
29.4
0.83
42
171
(42529406) Shigella sp [Presence] in Stool by Culture
43
156
2.87
8.97
1.6
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
19
39
4.98
8.88
2.1
1.2
u/ml
0.2
1.0
0.41
11
22
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
19
39
4.98
8.88
1.5
1.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
34
109
3.23
8.75
5.2
3.3
%
59.8
57.2
0.44
34
109
(3017732) Neutrophils [#/volume] in Blood
72
339
2.25
8.75
3.2
2.7
e9/l
4.7
4.2
0.64
48
248
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
502
4190
1.67
8.74
4.7
3.8
pmol/l
15.2
15.0
0.82
458
3730
(3030905) Polymorphonuclear cells [#/volume] in Blood
33
104
3.28
8.73
4.0
3.1
e9/l
4.3
4.2
0.01
33
104
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
10
10
10.13
8.66
1.1
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
256
1817
1.64
8.63
5.9
3.2
e6/l
26.1
78.0
3.47
225
1412
(3024471) HLA-A [Type]
13
8
16.53
8.57
1.0
1.0
—
—
—
0
0
(3012501) Base excess in Blood by calculation
37
127
3.02
8.51
5.7
4.6
mmol/l
2.4
2.6
0.12
28
89
(40760888) Immunoglobulin light chains.free panel - Serum
41
151
2.82
8.33
3.5
4.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
37
129
2.97
8.29
1.2
1.3
u/ml
5.8
3.1
—
5
18
(3017817) Protein [Mass] in Urine collected for unspecified duration
21
50
4.30
8.24
2.2
2.4
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
18
38
4.83
8.15
1.7
1.1
titre
38.0
120.0
—
5
6
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
52
219
2.48
8.12
3.7
2.5
g/l
8.7
10.5
2.01
38
184
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
37
131
2.92
8.07
1.2
1.3
u/ml
16.9
3.1
—
7
24
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
33
110
3.10
7.98
1.3
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
286
2116
1.59
7.98
6.6
3.7
e6/l
68.1
113.8
0.50
242
1520
(3003327) Ova and parasites identified in Stool by Light microscopy
36
127
2.93
7.91
2.0
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
26
75
3.56
7.88
1.1
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
63
294
2.25
7.82
17.9
11.0
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
48
199
2.51
7.75
4.5
3.0
g/l
0.9
1.1
0.20
38
171
(3024932) HLA-DR beta [Type]
12
8
15.22
7.73
1.0
1.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
53
232
2.39
7.62
3.7
2.5
g/l
3.5
3.7
0.48
36
170
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
51
220
2.42
7.57
3.7
2.6
g/l
3.4
3.2
0.63
36
173
(3017315) Amylase [Enzymatic activity/volume] in Urine
11
15
7.43
7.57
1.6
1.1
u/l
199.0
368.1
0.34
11
15
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
14
25
5.69
7.57
1.5
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
14
25
5.69
7.57
1.5
1.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
53
233
2.38
7.55
3.7
2.5
g/l
7.8
7.6
0.28
36
176
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
53
233
2.38
7.55
3.7
2.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
23
63
3.74
7.51
3.6
1.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
13
22
6.00
7.40
1.4
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
23
64
3.68
7.35
2.1
2.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
622
5596
1.88
7.33
44.3
14.4
mg/l
26.5
26.1
0.12
581
4439
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
24
69
3.56
7.32
1.1
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
81
429
2.00
7.27
6.6
4.0
%
0.0
0.1
0.66
34
109
(40768441) Liver Pathology biopsy report
17
38
4.56
7.21
2.4
1.0
—
—
—
0
0
(3019225) pH of Specimen
98
557
1.88
7.15
6.2
4.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
41
164
2.59
7.13
3.9
3.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
20
52
3.93
7.02
3.9
2.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
16
35
4.65
6.96
4.5
1.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
41
167
2.54
6.88
2.4
1.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
17
40
4.33
6.78
1.1
1.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
52
238
2.28
6.78
1.8
1.9
u/l
38.3
37.3
0.14
47
200
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
15
32
4.77
6.71
1.5
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
15
32
4.77
6.71
1.5
1.3
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
10
14
7.23
6.71
1.3
1.1
g/l
7.3
17.0
—
5
8
(36660697) Celiac disease serology panel - Serum
65
328
2.08
6.65
1.2
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
108
647
1.79
6.64
3.6
4.3
ug/l
6.5
15.3
0.67
89
531
(3024891) Influenza virus A+B Ag [Presence] in Specimen
33
123
2.76
6.59
1.3
1.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
42
178
2.44
6.50
12.5
6.8
mmol/l
1.1
1.2
0.29
34
156
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
11
18
6.19
6.44
1.2
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
20
56
3.65
6.35
1.3
1.3
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
39
162
2.49
6.30
3.9
2.7
g/l
0.0
0.0
0.00
32
151
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
12
22
5.53
6.30
1.4
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
19
5.86
6.12
1.2
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
19
5.86
6.12
1.2
1.0
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
41
177
2.40
6.11
3.8
2.7
g/l
0.1
0.0
0.32
34
162
(40768443) Skin Pathology biopsy report
52
249
2.17
6.10
1.8
1.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
39
165
2.44
6.07
3.9
2.7
g/l
0.0
0.0
0.00
32
152
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
23
73
3.22
6.06
1.2
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
15
35
4.36
6.05
1.3
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
15
35
4.36
6.05
1.3
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
145
965
1.63
6.05
5.1
3.0
e6/l
1.9
2.1
0.17
97
537
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
21
63
3.40
6.04
1.1
1.1
g/l
1.5
1.5
0.18
16
56
(40767503) Oxygen content in Capillary blood by calculation
33
129
2.63
6.04
3.3
2.2
%
14.6
15.7
0.91
21
63
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
13
27
4.89
5.99
2.8
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
316
2501
1.47
5.94
19.4
9.6
e9/l
0.0
0.0
0.55
275
2061
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
23
74
3.18
5.94
1.3
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
13
28
4.71
5.75
2.8
1.5
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
10
17
5.95
5.64
2.7
1.5
ug/l
33.1
62.9
—
10
17
(3009508) Creatinine [Moles/volume] in Urine
246
1869
1.48
5.61
3.9
3.0
mmol/l
6.3
7.5
5.20
212
1544
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
113
721
1.67
5.53
1.6
1.4
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
28
106
2.71
5.46
3.2
1.4
nmol/l
0.9
0.9
0.11
22
89
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
42
193
2.25
5.46
3.8
2.5
g/l
34.3
37.3
2.01
32
160
(3024928) Oxygen saturation in Venous blood
32
130
2.53
5.44
6.1
2.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
132
1888
0.63
5.36
3.7
3.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
13
30
4.40
5.31
2.4
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
250
1922
1.46
5.31
4.9
3.8
mg/mmol
19.3
8.3
1.79
181
1191
(4035726)
86
515
1.76
5.29
1.7
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
15
39
3.91
5.28
1.6
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
55
286
2.00
5.22
3.0
3.1
pmol/l
3.9
4.5
3.63
39
247
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
5
0
+∞
5.21
1.0
0.0
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
5
0
+∞
5.21
1.0
0.0
—
—
—
0
0
(4268621)
17
49
3.53
5.20
2.2
2.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
26
98
2.72
5.13
2.9
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
31
128
2.49
5.11
1.7
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
11
23
4.84
5.02
1.2
1.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
102
650
1.66
5.01
5.4
3.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
11
24
4.64
4.79
2.1
1.5
g/l
1.0
1.0
0.07
11
24
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
8
7
11.54
4.79
3.4
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
33
3.99
4.73
2.8
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
235
1820
1.43
4.69
4.1
3.1
mg/l
837.9
266.6
0.73
174
1132
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
50
262
1.98
4.67
10.9
5.0
%
1.4
1.6
0.95
45
249
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
14
38
3.74
4.66
1.1
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
11
26
4.28
4.37
4.8
4.9
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
12
7.58
4.36
2.1
2.0
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
9
12
7.58
4.36
1.1
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
15
45
3.38
4.34
1.5
1.2
—
—
—
0
0
(4034850)
38
185
2.11
4.33
14.8
10.7
—
—
—
0
0
(3000492) Spirometry study
75
458
1.71
4.32
2.0
1.5
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
7
6
11.76
4.28
1.1
3.8
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
16
51
3.19
4.23
1.6
1.1
—
—
—
0
0
(4015189)
9
13
6.99
4.17
2.3
2.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
17
58
2.98
4.03
1.1
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
20
75
2.71
4.02
1.3
1.1
u/ml
12.5
2.8
0.94
11
20
(21494755) Public health laboratory ask at order entry panel
13
371
0.34
4.01
1.2
1.4
—
—
—
0
0
(4306422)
18
64
2.86
3.98
1.3
1.2
—
—
—
0
0
(3019977) pH of Arterial blood
12
33
3.68
3.93
1.9
4.5
ph
7.4
7.4
—
6
8
(3047189) Immunofixation for 24 hour Urine
12
33
3.68
3.93
2.3
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
13
38
3.47
3.91
1.5
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
8
11
7.34
3.86
1.0
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
14
44
3.23
3.79
2.9
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
18
66
2.77
3.78
4.8
3.9
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
9
16
5.68
3.66
1.1
1.7
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
80
520
1.61
3.65
6.9
3.5
mmol/l
1.2
1.2
2.03
71
451
(3032057) Clostridioides difficile [Presence] in Stool
8
13
6.21
3.51
2.1
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
8
244
0.32
3.50
1.1
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
18
69
2.65
3.49
1.8
1.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
10
27
3.74
3.36
1.2
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
12
37
3.28
3.35
4.2
3.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
16
59
2.75
3.34
3.8
3.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
65
2.65
3.32
1.0
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
19
77
2.51
3.32
1.3
1.1
u/ml
5.4
6.4
—
9
26
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
558
5141
1.39
3.30
6.0
4.6
mu/l
1.8
2.2
0.91
506
4602
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
22
97
2.31
3.22
4.5
2.6
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
8
15
5.38
3.20
1.9
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
22
98
2.28
3.15
1.1
1.2
u/l
30.9
25.7
0.13
16
79
(3003694) ABO and Rh group [Type] in Blood
186
1469
1.36
3.13
1.4
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
38
210
1.86
3.10
1.1
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
6
8
7.55
3.06
1.2
1.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
120
886
1.43
3.01
1.3
1.2
iu/ml
101.4
37.2
1.23
38
275
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
12
40
3.03
2.98
1.0
1.1
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
5
5
10.06
2.98
1.6
1.4
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
9
6.71
2.87
1.3
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
9
6.71
2.87
1.3
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
19
84
2.30
2.79
1.7
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
14
54
2.62
2.71
1.0
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
100
1334
0.71
2.62
3.0
3.1
ug/l
0.9
0.8
0.31
76
919
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
15
4.70
2.60
1.1
1.7
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
19
87
2.22
2.59
5.4
2.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
8
20
4.03
2.57
1.0
1.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
29
157
1.88
2.56
3.1
2.3
ug/min
63.3
81.9
0.32
18
87
(44813793)
10
33
3.06
2.53
1.1
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
23
115
2.03
2.53
1.2
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
20
95
2.14
2.51
2.1
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
16
4.41
2.48
2.4
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
7
16
4.41
2.48
1.3
2.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
12
45
2.70
2.46
2.3
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
12
5.03
2.40
1.0
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
44
276
1.63
2.37
1.3
1.6
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
8
6.28
2.37
1.0
1.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
19
369
0.50
2.37
1.7
1.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
15
65
2.34
2.33
1.2
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
19
92
2.09
2.29
1.7
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
23
120
1.95
2.28
1.1
1.1
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
6
13
4.64
2.27
1.8
1.8
umol/l
4.1
4.1
—
6
13
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
13
4.64
2.27
1.3
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
52
345
1.55
2.24
2.3
2.5
—
16.4
—
0
15
(3027008) Opiates [Presence] in Urine
19
93
2.07
2.23
1.7
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
19
93
2.07
2.23
1.7
1.3
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
14
60
2.36
2.23
1.3
1.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
9
5.59
2.21
1.2
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
19
94
2.05
2.17
1.7
1.3
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
6
14
4.31
2.15
3.2
2.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
94
708
1.38
2.12
4.4
4.7
%
34.5
32.0
1.06
60
439
(3045142) Bone marrow Pathology biopsy report
15
68
2.23
2.12
1.1
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
12
49
2.47
2.11
1.3
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
10
37
2.73
2.11
1.3
1.9
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
27
153
1.79
2.11
1.8
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
69
493
1.44
2.10
6.7
3.7
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
5
10
5.03
2.07
1.6
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
10
5.03
2.07
1.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
10
5.03
2.07
1.4
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
7
20
3.52
2.06
2.7
1.3
ug/l
9.7
8.9
—
7
20
(3033799) Differential panel - Peritoneal fluid
6
15
4.02
2.04
1.3
2.5
—
—
—
0
0
(3004451) EKG impression Narrative
9
32
2.84
2.00
1.0
1.3
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
16
77
2.10
1.98
2.5
1.8
u/l
225.2
354.4
—
6
23
(3019550) Sodium [Moles/volume] in Serum or Plasma
620
5935
1.35
1.92
47.2
17.0
mmol/l
138.5
139.7
17.22
609
5763
(3019230) Fractional oxyhemoglobin in Venous blood
19
99
1.94
1.92
7.2
2.7
%
65.5
58.8
0.63
19
99
(3023103) Potassium [Moles/volume] in Serum or Plasma
621
5951
1.34
1.86
47.3
17.1
mmol/l
4.0
4.0
0.01
609
5776
(40759836) Histone Ab [Presence] in Serum by Immunoblot
10
40
2.52
1.84
1.3
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
10
40
2.52
1.84
1.3
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
10
40
2.52
1.84
1.3
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
20
108
1.88
1.83
1.5
1.6
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
9
35
2.59
1.80
1.7
3.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
8
29
2.78
1.79
1.4
1.4
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
20
109
1.86
1.79
1.1
1.1
—
9.4
—
0
13
(40768800) Prostate Pathology biopsy report
6
152
0.39
1.78
1.0
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
10
41
2.46
1.76
1.1
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
10
41
2.46
1.76
1.3
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
10
41
2.46
1.76
1.3
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
10
41
2.46
1.76
1.3
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
24
2.93
1.72
1.0
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
21
118
1.80
1.72
2.0
1.2
e6/l
3.9
56.8
0.64
15
92
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
21
118
1.80
1.72
2.1
1.3
e6/l
643.4
1058.1
0.16
16
96
(3030981) Hyaline casts [#/volume] in Urine by Automated count
47
326
1.47
1.70
3.9
2.7
e6/l
0.2
0.3
0.31
47
318
(3041096) Erythrocytes [Presence] in Urine by Automated
176
1490
1.24
1.68
6.2
3.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
12
55
2.20
1.68
1.8
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
31
2.60
1.66
1.0
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
25
2.82
1.65
1.0
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
610
5858
1.29
1.59
36.9
13.7
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
20
3.02
1.58
1.3
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
7
26
2.71
1.58
1.0
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
33
2.44
1.54
2.0
1.6
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
15
3.35
1.52
1.0
3.0
%
223.4
153.8
—
5
15
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
15
3.35
1.52
1.0
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
12
58
2.09
1.50
1.4
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
14
72
1.96
1.49
2.4
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
28
2.51
1.45
1.4
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
11
52
2.13
1.45
2.7
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
15
81
1.87
1.41
2.2
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
46
2.19
1.40
3.0
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
7
29
2.43
1.39
2.9
12.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
7
29
2.43
1.39
1.3
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
11
53
2.09
1.39
1.2
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
6
23
2.62
1.37
1.2
1.1
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
15
82
1.85
1.36
1.6
1.4
g/l
27.6
32.3
0.51
15
73
(3043410) Blood group antigens tested for on Red Blood Cells
5
17
2.95
1.36
1.8
1.5
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
5
17
2.95
1.36
1.6
3.5
%
70.8
51.1
—
5
17
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
11
54
2.05
1.33
1.2
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
103
848
1.25
1.27
1.3
1.2
u/ml
21.9
11.6
0.40
38
312
(3037121) Protein [Mass/volume] in Urine
31
212
1.48
1.25
3.4
3.2
g/l
0.4
0.2
0.56
21
87
(3014271) Vancomycin [Susceptibility]
8
36
2.24
1.24
3.1
2.3
—
—
—
0
0
(3035880) pH of Pleural fluid
8
37
2.18
1.21
1.1
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
621
6017
1.25
1.21
22.7
10.2
u/l
24.4
25.3
0.95
604
5776
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
558
5352
1.20
1.19
8.3
6.0
mmol/mol
42.5
40.2
2.66
518
4894
(3015183) Erythrocyte sedimentation rate
5
21
2.39
1.09
1.8
1.4
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
22
2.28
1.03
1.2
1.0
iu/ml
75.9
106.8
—
5
22
(3017704) Immunofixation for Urine
7
35
2.01
1.00
1.3
1.8
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
12
69
1.75
0.97
1.3
1.1
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
7
37
1.90
0.94
1.1
1.3
—
28.8
—
0
6
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
28
2.15
0.91
1.3
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
14
86
1.64
0.91
1.2
1.1
—
—
—
0
0
(4146454)
11
64
1.73
0.86
1.8
2.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
6
31
1.94
0.84
7.5
1.9
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
8
45
1.79
0.84
1.5
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
554
5360
1.15
0.83
32.2
13.9
ml/min/173m2
74.6
76.8
1.34
486
4394
(3017446) Testosterone [Moles/volume] in Serum or Plasma
50
402
1.26
0.81
2.5
2.2
nmol/l
12.0
12.7
0.22
45
353
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
34
1.77
0.76
1.0
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
166
1831
0.88
0.76
5.0
4.4
%
20.2
21.7
0.85
89
955
(3009542) Hematocrit [Volume Fraction] of Blood
519
5014
1.13
0.74
38.2
15.7
%
36.2
39.3
8.10
284
3370
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
16
108
1.49
0.74
1.4
1.3
miu/ml
161.7
246.4
—
6
46
(40768795) Lymph node Pathology biopsy report
11
68
1.63
0.72
1.4
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
12
76
1.59
0.72
1.0
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
26
1.93
0.70
1.0
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
26
1.93
0.70
2.0
2.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
24
178
1.36
0.69
1.8
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
27
1.86
0.68
1.0
1.3
nmol/l
111.2
142.7
—
5
27
(3045788) Cell count panel - Pleural fluid
9
59
1.53
0.68
1.6
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
48
581
0.81
0.68
1.8
1.6
—
—
—
0
0
(4024509)
7
44
1.60
0.65
2.3
1.3
—
—
—
0
0
(4027681)
5
29
1.73
0.64
1.2
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
21
156
1.36
0.61
4.4
3.2
nmol/l
1.0
0.9
0.39
16
129
(1761482) Bacteria [#/volume] in Urine by Culture
23
174
1.33
0.60
6.6
4.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
7
112
0.62
0.58
1.9
1.6
—
—
—
0
0
(4211845)
6
35
1.72
0.57
7.5
1.8
—
—
—
0
0
(3002256) Pathology report gross observation
84
742
1.15
0.55
1.3
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
8
125
0.64
0.55
3.9
2.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
39
327
1.20
0.48
1.3
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
17
128
1.34
0.48
1.5
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
568
5563
1.10
0.48
5.9
4.7
mmol/l
6.2
6.0
1.06
513
4975
(3011648) Oxygen content in Venous blood
7
47
1.49
0.47
1.3
1.6
%
11.3
10.4
—
7
47
(3045414) Leukocytes [Presence] in Urine
28
228
1.24
0.46
2.7
1.9
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
31
1.62
0.43
1.6
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
31
258
1.21
0.42
2.9
3.0
—
—
—
0
0
(3044889) 12 lead EKG panel
430
4175
1.08
0.41
6.1
4.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
58
1.38
0.41
1.3
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
33
1.52
0.41
2.6
2.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
35
296
1.19
0.41
1.3
1.2
iu/ml
162.5
130.3
0.21
12
115
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
2.4
—
2.6
—
0
8
(3035933) Granulocytes/100 leukocytes in Blood
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
66
1.37
0.38
1.9
1.7
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
10
72
1.39
0.37
1.5
1.3
e6/l
1960.6
1820.9
—
10
48
(3023511) Choriogonadotropin [Units/volume] in Urine
6
43
1.40
0.35
1.2
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
165
1569
1.07
0.29
1.7
1.7
mmol/l
1.5
1.4
1.34
145
1308
(3003740) Influenza virus B Ag [Presence] in Specimen
7
57
1.23
0.29
1.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
34
299
1.14
0.28
1.9
1.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
8
65
1.23
0.27
1.9
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
19
159
1.20
0.27
1.3
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
67
1.20
0.26
1.7
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
16
191
0.83
0.24
1.6
1.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
565
5718
0.94
0.24
5.9
5.1
mmol/l
2.4
2.7
10.09
516
5173
(3000330) Specific gravity of Urine by Test strip
34
304
1.12
0.23
7.0
3.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
36
324
1.12
0.22
1.9
1.8
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
629
6237
1.07
0.22
59.6
21.3
e9/l
254.6
245.0
2.23
619
6043
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
73
682
1.08
0.22
1.7
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
42
1.19
0.21
1.0
1.0
titre
—
—
—
0
0
(3024731) MCV [Entitic volume]
629
6238
1.07
0.21
59.3
21.2
fl
91.7
91.4
0.72
622
6120
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.1
—
16.9
—
0
10
(3035941) MCH [Entitic mass]
629
6239
1.07
0.21
59.2
21.2
pg
30.2
30.4
1.15
622
6121
(3026361) Erythrocytes [#/volume] in Blood
629
6240
1.07
0.20
59.7
21.3
e12/l
4.2
4.5
29.26
617
6027
(3014891) Appearance of Pleural fluid
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
629
6241
1.07
0.20
59.9
21.4
g/l
124.5
134.8
42.78
620
6121
(3010813) Leukocytes [#/volume] in Blood
629
6241
1.07
0.20
59.8
21.3
e9/l
7.3
6.8
5.60
617
6027
(3002523) Influenza virus A Ag [Presence] in Specimen
7
58
1.21
0.18
1.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
60
1.17
0.18
1.3
1.1
nmol/l
—
—
—
0
0
(4094501)
12
142
0.84
0.17
1.1
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
8
68
1.18
0.16
2.3
1.5
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
8
69
1.16
0.16
1.8
1.2
nmol/l
0.8
0.6
—
8
63
(40768793) Breast Pathology biopsy report
12
141
0.85
0.16
1.3
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
554
5589
0.96
0.15
5.4
4.6
mmol/l
4.3
4.6
6.64
506
5079
(3002385) Erythrocyte distribution width [Ratio]
460
4652
0.97
0.14
45.1
17.6
%
14.7
13.8
17.07
454
4548
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
550
5545
0.96
0.13
5.3
4.5
mmol/l
1.5
1.5
0.18
500
5000
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
9
109
0.82
0.13
1.9
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
221
2257
0.97
0.13
5.2
5.2
ug/l
2.5
3.5
0.87
197
2010
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
5
65
0.77
0.08
1.0
1.2
mmol/l
6.2
7.9
—
5
44
(4281824)
7
65
1.08
0.08
1.1
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
15
137
1.10
0.07
1.7
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
15
162
0.92
0.06
1.1
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
537
5349
1.02
0.05
5.0
4.0
mmol/l
1.3
1.3
0.40
482
4784
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
15
158
0.95
0.02
1.4
1.8
—
—
—
0
0
(1002224) Polysomnography panel
18
188
0.96
0.02
1.1
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
39
382
1.02
0.01
5.7
3.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
10
95
1.05
0.00
1.5
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
12
125
0.96
0.00
1.4
1.7
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
1.8
—
0
6
(44806071)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
25.0
—
0
9
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
13
130
1.00
0.00
2.2
1.7
nmol/l
48.8
41.1
0.40
13
124
(3005570) Glucose [Moles/volume] in Urine
7
70
1.00
0.00
1.3
2.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
7
0.00
-0.00
0.0
3.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint K11_DISOESINOTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| K11_DISOESINOTH | 2.565 [2.19, 3.01] | < 0.001 |
| Birth year | 0.999 [0.99, 1.01] | 0.903 |
During the follow-up period (1.1.1998 — 31.12.2019), 765 out of 1795 females with K11_DISOESINOTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| K11_DISOESINOTH | 3.311 [2.69, 4.07] | < 0.001 |
| Birth year | 0.985 [0.97, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 950 out of 1818 males with K11_DISOESINOTH died.
Mortality risk
Mortality risk for people of age
years, who have K11_DISOESINOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.301% | 0.578% |
| 5 | 1.533% | 3.549% |
| 10 | 4.232% | 8.764% |
| 15 | 8.451% | 15.944% |
| 20 | 14.532% | 26.073% |
Relationships between endpoints
↥Index endpoint: K11_DISOESINOTH – Disorders of oesophagus in diseases classified elsewhere
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data